Medpace Holdings, Inc. (MEDP)


-2.55 (-1.04%)
Symbol MEDP
Price $242.15
Beta 1.375
Volume Avg. 0.29M
Market Cap 7.401B
Shares () -
52 Week Range 149.07-282.73
1y Target Est -
DCF Unlevered MEDP DCF ->
DCF Levered MEDP LDCF ->
ROE 72.88% Strong Buy
ROA 19.10% Buy
Operating Margin -
Debt / Equity 49.71% Neutral
P/E 30.50 Strong Buy
P/B 18.91 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest MEDP news

Dr. August James Troendle M.D.
Diagnostics & Research
NASDAQ Global Select

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.